Price Alert

Clorox (CLX)

NYSE: CLX · Real-Time Price · USD

122.16

0.58 (0.48%)

At close: Aug 15, 2025, 12:31 PM

Clorox Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Cash & Equivalents	167M	226M	290M	278M	202M	219M	355M	518M	367M	242M	168M	278M	183M	241M	192M	210M	319M	492M	732M	860M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	558M	537M	548M	524M	545M	556M	486M	486M	462M	427M	331M	311M	315M	364M	376M	368M	378M	386M	357M	332M
Receivables	821M	597M	603M	595M	695M	673M	679M	581M	688M	678M	600M	612M	681M	660M	569M	654M	604M	643M	616M	685M
Inventory	523M	635M	592M	594M	637M	674M	655M	710M	696M	735M	741M	755M	755M	803M	818M	785M	752M	688M	609M	534M
Other Current Assets	97M	132M	147M	109M	88M	95M	115M	102M	77M	90M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	1.61B	1.59B	1.63B	1.58B	1.62B	1.66B	1.8B	1.91B	1.83B	1.75B	1.62B	1.76B	1.73B	1.87B	1.74B	1.82B	1.83B	1.96B	2.1B	2.14B
Property-Plant & Equipment	1.6B	1.59B	1.6B	1.58B	1.68B	1.67B	1.67B	1.65B	1.69B	1.67B	1.67B	1.66B	1.68B	1.62B	1.61B	1.61B	1.63B	1.58B	1.54B	1.46B
Goodwill & Intangibles	1.79B	1.79B	1.79B	1.81B	1.91B	1.92B	1.95B	1.95B	1.96B	1.97B	2.42B	2.42B	2.44B	2.47B	2.46B	2.48B	2.49B	2.51B	2.85B	2.84B
Total Long-Term Assets	3.95B	3.92B	3.94B	3.92B	4.13B	4.14B	4.1B	4.08B	4.12B	4.07B	4.42B	4.39B	4.43B	4.45B	4.45B	4.45B	4.5B	4.48B	4.75B	4.63B
Total Assets	5.56B	5.51B	5.58B	5.5B	5.75B	5.8B	5.91B	5.99B	5.95B	5.82B	6.04B	6.15B	6.16B	6.32B	6.19B	6.27B	6.33B	6.44B	6.86B	6.78B
Account Payables	838M	2.02B	1.46B	1.47B	950M	1.65B	1.65B	1.68B	1.02B	1.72B	n/a	n/a	960M	1.57B	1.54B	1.58B	930M	1.45B	1.38B	1.4B
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	4M	54M	189M	4M	4M	111M	247M	347M	50M	138M	209M	348M	237M	995M	983M	985M	300M	300M	300M	n/a
Other Current Liabilities	179M	n/a	n/a	n/a	190M	n/a	n/a	n/a	262M	n/a	1.59B	1.58B	176M	n/a	n/a	n/a	219M	n/a	n/a	n/a
Total Current Liabilities	1.92B	2.15B	1.73B	1.58B	1.57B	1.85B	2.02B	2.23B	1.92B	2B	1.88B	2.01B	1.78B	2.64B	2.6B	2.64B	2.06B	1.82B	1.74B	1.52B
Long-Term Debt	2.48B	2.48B	2.48B	2.48B	2.48B	2.48B	2.48B	2.48B	2.48B	2.48B	2.48B	2.48B	2.47B	1.89B	1.89B	1.89B	2.48B	2.48B	2.48B	2.78B
Other Long-Term Liabilities	351M	341M	882M	874M	848M	853M	852M	837M	825M	824M	826M	805M	791M	843M	861M	846M	834M	819M	813M	797M
Total Long-Term Liabilities	3.16B	3.17B	3.73B	3.69B	3.69B	3.7B	3.67B	3.63B	3.64B	3.65B	3.68B	3.65B	3.65B	3.1B	3.1B	3.09B	3.69B	3.68B	3.74B	3.95B
Total Liabilities	5.08B	5.32B	5.46B	5.27B	5.26B	5.55B	5.69B	5.86B	5.56B	5.65B	5.55B	5.66B	5.43B	5.75B	5.7B	5.73B	5.74B	5.5B	5.47B	5.47B
Total Debt	2.88B	2.94B	3.09B	2.88B	2.9B	3.02B	3.13B	3.2B	2.92B	3.02B	3.08B	3.21B	3.1B	3.24B	3.23B	3.23B	3.17B	3.16B	3.16B	3.11B
Common Stock	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	131M	159M
Retained Earnings	432M	99M	68M	31M	250M	34M	241M	299M	583M	415M	782M	832M	1.05B	951M	949M	1.03B	1.04B	1.09B	1.3B	3.84B
Comprehensive Income	-157M	-176M	-181M	-147M	-155M	-155M	-359M	-494M	-493M	-498M	-502M	-515M	-479M	-519M	-574M	-567M	-546M	-553M	-575M	-623M
Shareholders Equity	321M	27M	-41M	60M	328M	91M	53M	-37M	220M	3M	321M	326M	556M	400M	313M	368M	411M	743M	1.18B	1.11B
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a